The selective vulnerability of brainstem nuclei to Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

http://www.wikidata.org/entity/Q53240462

about

Mild cognitive impairment: pathology and mechanisms.Neurocardiovascular Instability and Cognition Alzheimer's therapeutics: translation of preclinical science to clinical drug development Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?The preclinical phase of the pathological process underlying sporadic Alzheimer's disease Hearing and dementia.Assessment of brainstem function with auricular branch of vagus nerve stimulation in Parkinson's disease.Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.Pathology of the insular cortex in Alzheimer disease depends on cortical architecture.Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease.Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: validation in the cerebellum and brainstem Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.The role of serotonin in respiratory function and dysfunction.Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy Passive (amyloid-β) immunotherapy attenuates monoaminergic axonal degeneration in the AβPPswe/PS1dE9 mice.Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease.Targeting axonal protein synthesis in neuroregeneration and degeneration.Localization of mutant ubiquitin in the brain of a transgenic mouse line with proteasomal inhibition and its validation at specific sites in Alzheimer's disease Brainstem morphological changes in Alzheimer's disease.Age-related hearing impairment and frailty in Alzheimer's disease: interconnected associations and mechanisms.Hearing loss and incident dementia.Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease.Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation Does Alzheimer's disease begin in the brainstem?Epigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer's disease: looking in the correct place at the right time?Altered sleep and EEG power in the P301S Tau transgenic mouse model.Neuropathology of sleep disorders: a review.Alzheimer's pathogenesis: is there neuron-to-neuron propagation?Eye movements in Alzheimer's disease.Correlations between cortical and subcortical tau pathology.Age-related hearing impairment-a risk factor and frailty marker for dementia and AD.Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo.Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease.Visual system manifestations of Alzheimer's disease.

P2860

Q24631255-D8B66316-D811-4F5F-A2DB-0B5A25D8A65D Q26738343-933F5897-756F-48C7-B38E-FBE51B06DF0B Q26829267-90055958-1631-4AED-88A2-04A38DD1CE4B Q27027221-106EA21F-09A2-45B7-97ED-6C93A0B5288B Q28070156-343A4C27-C389-46BD-B2AE-2378663C77A6 Q28083428-790066F1-4D25-413D-88AE-255EAA7A8288 Q30249183-DA6D3E01-3B33-4E10-9E09-01A8C8648C8D Q30413998-065959F4-2278-442A-B9FE-8F7C5DD934E8 Q30844298-6583C8B7-940C-4325-A88D-AFFCA4209F60 Q33224917-FDC5FAD4-F88A-458E-BE3D-66E12EEA3B8F Q33665060-C61F2C93-B865-4C4E-8FBE-5760C8647D60 Q33849163-837FADD6-4885-410F-BD71-46CFB23D86FE Q34154830-7F6DCFDD-F670-46A8-8C1A-FD2392C2BC17 Q34357201-182F0262-876B-4F0D-85EC-6DA5646840CF Q34405999-37241663-430B-41F0-9E04-E949B801120C Q34604164-C2C9EDEB-4051-4383-A635-8B89923AD3F5 Q34717836-BA7D8093-B506-4842-94A2-E1A213286178 Q34903853-63D3A0F0-7D0D-4AC6-AB0D-60177FF51028 Q35064944-9D4BCD67-6B75-41D5-AB09-ED809A5E190B Q35184113-5FC594D7-E312-4D77-B643-92357199F886 Q35556809-F3B383DB-0E86-46E4-B022-3E2165D0AC90 Q35698827-84FBAFCE-37A6-4EF4-AD0D-7393981819DC Q35751911-A420660C-BE18-465C-B4EA-0BEC3BE916ED Q35978920-12BB1485-57B3-4278-B172-EB314F39F985 Q36105261-A4A32110-615C-474D-9F81-54C9D6B4CC5F Q36484091-494B2B59-D0EC-4A21-96FD-57AE635BB8B8 Q37010623-B7C27687-74E0-4A70-9BAA-E69EB82CA15D Q37293041-1AFC7ADD-1C19-4647-900B-88671B1E41A3 Q37456054-DD1722CC-6700-42C1-A7A0-E9655AFA6504 Q37590630-D40BEEA7-BCB9-41E9-9009-D3D1608E1F51 Q37681990-1A454860-C785-485E-BCCF-A6E5454EE845 Q37853823-AC86C703-B268-46F9-ADE2-F0F7C2023088 Q37868480-CFEE964D-0C0C-408C-98F5-A50F546BF76A Q38245625-B9C66797-B675-48B0-93F0-F65B820C03AC Q38330008-BF4F0AC2-3308-4FAA-8458-F2C8E6490971 Q38357395-C6377822-E6F7-4A1A-A65D-1B6A1982F20C Q38597149-577F0185-0536-45A6-B9C9-711836714AAE Q38885797-220FC86C-F102-4A03-954D-5C518A9317F3 Q39002052-2435C0B3-62A4-438D-ABC6-BD48745B2C0B Q39013852-06AB367E-B50F-4436-AAC0-44A4C47A108A

P2860

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

http://www.wikidata.org/entity/Q53240462

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

@en

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

@nl

type

label

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

@en

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

@nl

prefLabel

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

@en

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

@nl

P1433

Q53240462-7CD835F3-0C49-4FA4-AF65-E0E2A8AC1986

P1476

Q53240462-169D5A2D-7310-4320-92CE-3255C819842A

P2093

Q53240462-3C8C4E43-8EBB-4F31-8F42-7CC7D577CDE4

Q53240462-C71127A1-3CE1-4A60-8029-E611CD58E4E9

Q53240462-F3826276-AEA4-4E14-B8D6-89F49523D4AC

P2860

Q53240462-0351D221-8C4A-4788-A5BE-C3CCF6039135

Q53240462-102AF5DF-7E08-41C0-8A97-39C2C13E1DEE

Q53240462-253C8C5E-4FF5-491B-9E20-D94D2DD76EBC

Q53240462-264EC70D-51BB-4754-ABA6-741BF07793D3

Q53240462-4F586BCC-DACF-4305-B979-E94197D4146A

Q53240462-50F80BE1-8B7C-4021-8472-8D9AAEFAEC57

Q53240462-550F4FFB-69E3-4724-9903-D290F07331E9

Q53240462-55F135DA-C181-4BBD-BFB1-8BFFFD487161

Q53240462-57FFF5C2-BA4D-44C9-ACEE-228D8E86DD26

Q53240462-5C1B6F7F-40F5-469B-B687-54557F6252A6

P304

Q53240462-A82DA47A-E9C1-47C1-9CDF-F5D31D0927DE

P31

Q53240462-85627713-B2E6-4DC4-9C08-988E1BE5B885

P356

Q53240462-A7CB3B81-4288-4110-8553-F819562FF513

P433

Q53240462-5A6E4882-39F8-4444-81B9-76FD976657F5

P478

Q53240462-D6E4B6F0-E7DA-4487-AD4B-E71705FE98D1

P577

Q53240462-7908E8CC-DEC2-4AFE-B48A-685A4ECFB08D

P698

Q53240462-E4683637-804C-41D6-AD73-D1CFA494E0C4

P356

1531-8249(200101)49:1%3C53::AID-ANA30%3E3.0.CO;2-Q

P1433

Annals of Neurology

P1476

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

@en

P2093

Damasio A

http://www.w3.org/2001/XMLSchema#string

Parvizi J

http://www.w3.org/2001/XMLSchema#string

Van Hoesen GW

http://www.w3.org/2001/XMLSchema#string

P2860

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons.

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.

The spinoparabrachial pathway: shedding new light on an old path.

The distribution of Alz-50 immunoreactivity in the normal human brain.

Serotonergic functions in arousal and motor activity.

Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.

Observed sleep/wakefulness and severity of dementia in an Alzheimer's disease special care unit.

The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat.

The topography of cell loss from locus caeruleus in Alzheimer's disease.

P304

53-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11198297

http://www.w3.org/2001/XMLSchema#string